Edwards Lifesciences Corporation

NYSE-EW

Assets	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Cash and Cash Equivalents	3,272.8	3,045.2	1,644.5	1,132.3	1,042.6	769
Cash and Cash Equivalents
Short-Term Investments	789.4	930.7	345.3	500.5	466.7	446.3
Short-Term Investments
Total Cash and Cash Equivalents	4,062.2	3,975.9	1,989.8	1,632.8	1,509.3	1,215.3
Accounts Receivable	697	609.1	778.3	771.5	754.4	643
Accounts Receivable, Net
Accounts and Other Receivables, Net
Other Receivables	205.6	118.3	56.1	56.6	—	56.1
Other Receivables
Total Trade Receivables	902.6	727.4	834.4	828.1	754.4	699.1
Inventories	1,141.7	1,086.7	1,024.7	903.5	980.2	875.5
Inventories
Other Current Assets	470.7	495.4	667.1	353.7	340.6	305.9
Deferred Income Taxes
Prepaid Expenses
Other Current Assets
Current Assets of Discontinued Operations
Total Current Assets	6,577.2	6,285.4	4,516	4,035.7	3,647	3,095.8
Total Current Assets
Net Property, Plant & Equipment	1,825.6	1,784.2	1,732.9	1,675.4	1,747.1	1,725.1
Property, Plant, and Equipment, Net
Operating Lease Right-of-Use Assets
Net Intangible Assets	1,172.8	1,176.6	417.1	399.4	431.4	285.2
Other Intangible Assets, Net
Goodwill	1,776.7	1,777.6	1,151	1,145.1	1,299.5	1,164.3
Goodwill
Long-Term Investments	298.5	307.9	353.3	583.9	856.2	1,239
Long-Term Investments
Other Long-Term Assets	1,837.9	1,724.5	1,929	1,523.7	1,022.8	783.1
Long-Term Accounts Receivable, Net
Deferred Income Taxes
Other Assets
Non-Current Assets of Discontinued Operations
Total Assets	13,488.7	13,055.3	10,099.3	9,363.2	9,004	8,292.5
Total Assets

Liabilities	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Accounts Payable	162.1	197.4	185.9	186.6	193	201.9
Accounts Payable
Accounts Payable and Accrued Liabilities
Accrued Expenses	1,214.4	1,282.4	902.4	856.4	939.9	795
Accrued and Other Liabilities
Short-Term Debt	—	—	—	—	—	—
Short-Term Debt
Current Portion of Leases	25.9	23.4	21.5	22.9	24.3	25.5
Operating Lease Liabilities
Other Current Liabilities	2.3	2	107.2	129.5	—	—
Contingent Consideration Liabilities
Current Liabilities of Discontinued Operations
Total Current Liabilities	1,404.7	1,505.2	1,217	1,195.4	1,157.2	1,022.4
Total Current Liabilities
Long-Term Debt	598	597.7	597.3	597	596.7	596.3
Long-Term Debt
Leases	78.7	78.9	74.2	65.2	63.5	69.5
Operating Lease Liabilities
Other Long-Term Liabilities	800.8	810.6	706.2	786.2	740.1	797.6
Contingent Consideration Liabilities
Taxes Payable
Uncertain Tax Positions
Litigation Settlement Accrual
Other Liabilities
Non-Current Liabilities of Discontinued Operations
Total Long-Term Liabilities	1,477.5	1,487.2	1,377.7	1,448.4	1,400.3	1,463.4
Total Liabilities	2,882.2	2,992.4	2,594.7	2,643.8	2,557.5	2,485.8
Total Liabilities

Equity	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Preferred Stock	—	—	—	—	—	—
Preferred Stock
Common Stock	657.6	654.8	653.5	650.5	649.1	646.3
Common Stock
Treasury Stock	-6,456.4	-6,192.3	-5,182.8	-5,024.5	-4,401	-4,144
Treasury Stock, at Cost
Additional Paid-in Capital	2,750	2,613.4	2,476.3	2,274.4	2,145.5	1,969.3
Additional Paid-in Capital
Accumulated Other Comprehensive Income	-264.1	-244.5	-220.2	-242.8	-255.5	-254.9
Accumulated Other Comprehensive Loss
Retained Earnings	13,858.2	13,167	9,710.6	8,992.4	8,237.6	7,590
Retained Earnings
Total Common Shareholders' Equity	10,545.3	9,998.4	7,437.4	6,650	6,375.7	5,806.7
Total Edwards Lifesciences Corporation Stockholders' Equity
Minority Interests and Other	61.2	64.5	67.2	69.4	70.8	—
Noncontrolling Interest
Total Shareholders' Equity	10,606.5	10,062.9	7,504.6	6,719.4	6,446.5	5,806.7
Total Stockholders' Equity
Total Liabilities and Shareholders' Equity	13,488.7	13,055.3	10,099.3	9,363.2	9,004	8,292.5
Total Liabilities and Equity